Model web site for medicines regulatory authorities
Exchange of experience
A first conference was held jointly with the Nordic Council of Medicines in September 2001 in Copenhagen. The main objective of this meeting was to identify the minimum quantity of information a DRA should have on its web site, to define how to assess a DRA web site and to get guidance on those subjects. Following this workshop, a report of the results of the discussions has been published (Pharmaceuticals and the Internet: Drug Regulatory Authorities’ perspectives).
An assessment (Pilot study on drug regulatory web sites: current status and future challenges) was carried out to provide a brief overview of the quality of the information currently contained on existing DRA web sites, through analysis of their content, in different languages and regions and at different levels of sophistication.
WHO has completed the development of its Model Web site for National Drug Regulatory Authorities in close collaboration with a selected group of WHO Member states; the Model Web site will then be field-tested for countries. Following field-testing and finalization of the Model Web site, supporting user manuals would be prepared.
Articles related to this activities are available in the WHO Drug Information (vol 15, Number 3&4, 2001).